Breast-specific gamma imaging in the detection of atypical ductal hyperplasia and lobular Neoplasia

Academic Radiology

Volumn 19, Issue 6, 2012, Pages 661-666

  Ling, Caroline M ^a   Coffey, Caitrín M ^a   Rapelyea, Jocelyn A ^a   Torrente, Jessica ^a   Teal, Christine B ^a   McSwain, Anita P ^a   Brem, Rachel F ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Atypical ductal hyperplasia; Breast specific gamma imaging; High risk breast lesions; Lobular carcinoma in situ; Lobular neoplasia

Indexed keywords

TRACER;

ADULT; AGED; ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BREAST BIOPSY; BREAST DISEASE; BREAST SPECIFIC GAMMA IMAGING; BREAST SURGERY; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOBULAR NEOPLASIA; MALE; PRIORITY JOURNAL; RADIODIAGNOSIS;

ADULT; AGE DISTRIBUTION; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DISTRICT OF COLUMBIA; FEMALE; HUMANS; MIDDLE AGED; PREVALENCE; RADIONUCLIDE IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84860636764     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2012.02.008     Document Type: Article

References (41)

1. Brem R.F., Petrovitch I., Rapelyea J.A., et al. Breast-specific gamma imaging with 99mTc-Sestamibi and magnetic resonance imaging in the diagnosis of breast cancer-a comparative study. Breast 2007, 13:465-469.
2. Brem R.F., Floerke A.C., Rapelyea J.A., et al. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology 2008, 247:651-657.
3. Brem R.F., Fishman M., Rapelyea J.A. Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study. Acad Radiol 2007, 14:945-950.
4. Brem R.F., Ioffe M., Rapelyea J.A., et al. Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging. Am J Roentgenol AJR 2009, 192:379-383.
5. Goldsmith S.J., Parsons W., Guiberteau M.J., et al. The SNM procedure guideline for breast scintigraphy with breast specific γ-cameras 1.0. J Nucl Med Technol 2010, 38:219-224.
6. American College of Radiology. Diagnostic modality accreditation program: nuclear medicine/PET accreditation program requirements. Revised June 27, 2011; accessed August 4, 2011. http://www.acr.org/accreditation/nuclear/nuc_med_reqs.aspx.
7. Brem R.F., Rapelyea J.A., Zisman G., et al. Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer. Radiology 2005, 237:274-280.
8. Rhodes D.J., Hruska C.B., Phillips S.W., et al. Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts. Radiology 2011, 258:106-118.
9. Brem R.F., Shahan C., Rapelyea J.A., et al. Detection of occult foci of breast cancer using breast-specific gamma imaging in women with one mammographic or clinically suspicious breast lesion. Acad Radiol 2010, 17:734-743.
10. Boecker W., Buerger H., Herbst H., et al. Atypical ductal hyperplasia. Preneoplasia of the breast 2006, 379-406. Elsevier, Munich. W. Boecker (Ed.).
11. Tavasolli F.A. Lobular and ductal intraepithelial neoplasia. Pathologe 2008, 29(Suppl 2):107-111.
12. Jackman R.J., Birdwell R.L., Ikeda D.M. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision?. Radiology 2002, 224:548-554.
13. Darling M.L., Smith D.N., Lester S.C., et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. Am J Roentgenol AJR 2000, 175:1341-1346.
14. Brem R.F., Sanow L., Behrndt V.S., et al. Reliability of atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. Am J Roentgenol AJR 1999, 172:1405-1407.
15. Page D.L., Dupont W.D., Rogers L.W., et al. Atypical hyperplastic lesions of the female breast: a long term follow up study. Cancer 1985, 55:2689-2708.
16. Rampaul R.S., Pinder S.E., Robertson J.F., et al. Lobular neoplasia. Preneoplasia of the breast 2006, 467-484. Elsevier, Munich. W. Boecker (Ed.).
17. Page D.L., Kidd T.E., Dupont W.D., et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991, 22:1232-1239.
18. Chuba P.J., Hamre M.R., Yap J., et al. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 2005, 23:5534-5541.
19. Page D.L., Schuyler P.A., Dupont W.D., et al. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003, 361:125-129.
20. Nayar R., Zhuang Z., Merino M.J., et al. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using microdissection and polymerase chain reaction. Hum Pathol 1997, 28:277-282.
21. Green A.R., Krivinskas S., Young P., et al. Loss of expression of chromosome 16q genes DPEP1 and TCF in lobular carcinoma in situ of the breast. Breast Cancer Res Treat 2009, 113:59-66.
22. Brem R.F., Lechner M.C., Jackman R.J., et al. Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. Am J Roentgenol AJR 2008, 190:637-641.
23. Liberman L. Clinical management issues in percutaneous core breast biopsy. Radiol Clin N Am 2000, 4:791-807.
24. Liberman L., Sama M., Susnik B., et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. Am J Roentgenol AJR 1999, 173:291-299.
25. Sohn V.Y., Arthurs Z.M., Kim F.S., et al. Lobular neoplasia: is surgical excision warranted?. Am Surgeon 2008, 74:172-177.
26. Page D.L., Simpson J.F. What is atypical lobular hyperplasia and what does it mean for the patient?. J Clin Oncol 2005, 23:5432-5433.
27. King M., Wiend S., Hale K., et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 2001, 286:2251-2256.
28. An act requiring the communication of mammographic breast density information to patients. Public Act No. 09-41, Connecticut, 2009. Accessed August 4, 2011. http://www.cga.ct.gov/2009/ACT/PA/2009PA-00041-R00SB-00458-PA.htm.
29. An act concerning regulation; article V: improving state healthcare programs with respect to mammography and breast cancer treatment. Illinois, 2009. Accessed August 4, 2011. http://www.ilga.gov/legislation/publicacts/fulltext.asp?Name=095%131045.
30. Delmon-Moingeon L.I., Piwnica-Worms D., Van den Abbeele A.D., et al. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990, 50:2198-2202.
31. Sharma S., Sharma M.C., Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 2005, 46:481-489.
32. Saslow D., Boetes C., Burke W., et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography. CA: A Cancer J Clinicians 2007, 57:75-89.
33. Port E.R., Park A., Borgen P.I., et al. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 2006, 14:1051-1057.
34. Tchou J., Nanjiang H., Rademaker A., et al. Acceptance of tamoxifen chemoprevention by physicians and women at risk. Cancer 2004, 100:1800-1806.
35. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI Evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007, 356:1295-1303.
36. Zhou M., Johnson N., Gruner S., et al. Clinical utility of breast-specific gamma imaging for evaluating disease extent in the newly diagnosed breast cancer patient. Am J Surg 2009, 197:159-163.
37. Hendrick R.E. Radiation doses and cancer risks from breast imaging studies. Radiology 2010, 257:246-253.
38. O'Connor M.K., Li H., Rhodes D.J., et al. Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast. Med Phys 2010, 37:6187-6198.
39. Wagenaar D.J., Hugg J.W., Moats R.A., et al. Low-dose molecular breast imaging in radiographically dense breasts. J Nucl Med 2011, 52:674.
40. Bohm-Velez M., Kieper D., Williams M.B., et al. A clinical evaluation of breast tissue uptake of Tc99m-sestamibi as a function of injected dose. J Nucl Med 2011, 52:667.
41. O'Connor M.K., Weinmann A.L., Tortorelli C.L., et al. Low-dose molecular breast imaging. J Nucl Med 2011, 52:670.